Generate evidence for market access
What is it?
The Accelerating Innovations into CarE (AICE) – Market Access Program accelerates health innovations that face evidentiary hurdles in achieving market access. The Program supports small-to-medium sized enterprises (SMEs) and real-world testing sites (Testing Sites) in carrying out clinical trials, feasibility studies or real-world trials to fast-track commercial progression and market adoption.
Alberta Innovates Client Journey and a Health Innovation Pathway1
The AICE – Market Access Program supports Alberta-based health technology SMEs in conducting clinical or real-world trials, anywhere in the world.
The AICE-Market Access Program improves Alberta’s competitiveness in the health innovation sector on a global scale.
SMEs who participate in the AICE – Market Access Program can expect to:
- Acquire evidence through clinical or real-world trials that support rapid market access and adoption,
- Progress towards commercialization across the all four Health Innovation Cycle domains – from clinical and end-user safety and feasibility to real-world implementation.
We will contribute 50% of total eligible project costs up to $600,000 CAD per Project, over a maximum term of 24 months.
The program is open to Alberta-based small- and medium-sized health technology innovation companies partnered with an independent clinical/user testing organization providing data and a potential buyer perspective.
Ideal Applicants have:
- Validated technology that outperforms its direct and indirect competitors that is regulatory approved or ready (ITA/CTA) for clinical testing;
- Ownership or exclusive rights to the technology;
- An experienced and well-rounded management team; and
- Acquired private investment and/or generating revenue from sales
This program is continually accepting applications.
- Intake form Read the Program Guide and then complete the AICE Validate/Market Access Intake Form via the online application portal
- Pre-application meeting We’ll meet with you to discuss your intake form and ensure the best program fit and provide guidance and support
- Application Complete the Full Application via the online application portal
Please note: You will need to create an account to access our online application portal. If you have any questions about the application process or concerns about your project’s eligibility, feel free to contact Alberta Innovates at any time.
- Program guide
- Online Intake & Application Portal
- Application Aid (Microsoft WORD)
- Example Project Methodology
- Investment agreement
AICE-Validate – this Program helps Alberta’s innovators overcome the hurdles associated with digital health technology commercialization, across the key domains of product-market fit, business readiness, regulatory compliance, and product development – from proof of feasibility to clinical and end-user safety and feasibility.
ImplementAB.digH – supports Alberta-based healthcare delivery organizations in carrying out health technology assessments and feasibility studies of novel, commercially available digital health innovations.
Alberta Innovates, Entrepreneurial Investments– Alberta Innovates offers a variety of related high-demand, entrepreneurial investment programs that are of interest to SMEs.
- National Institute for Health and Care Excellence (NICE) – provides evidence standards that enable innovators to determine what level of evidence may be required to facilitate adoption of digital health technologies.
- Alberta SPOR SUPPORT Unit (AbSPORU) – provides support for stakeholders in conducting patient-oriented research. AbSPORU bridges gaps between data, research evidence and healthcare practice.
- E-Learning Tool – Health Canada – resource intended to educate stakeholders on premarket regulatory requirements for medical devices in Canada.
- Alberta Clinical Research Roadmap – an interactive online navigator outlining the steps to setting up and conducting a clinical health research study within Alberta.
- ARECCI – helps practitioners, agencies and organizations identify and mitigate ethical risks in program evaluations, quality improvement projects, needs assessments, health innovations and knowledge translation.